| Human coagulation factor VIII |
II-6210/18,11,2009 |
Fanhdi, Powder and solvent for solution for injection, 250, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
161.16 |
32.23 |
193.39 |
4% |
6.45 |
167.61 |
33.52 |
201.13 |
16% |
25 |
192.61 |
38.52 |
231.13 |
|
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
26.03.2010 |
Неактивен |
902 |
| Toremifene |
EU/1/96/004/001 |
Fareston, Tablet, 60, mg, Pack: 30 |
Orion Corporation, Финландия |
Orion Corporation Orion Pharma - Финландия |
29.53 |
5.91 |
35.44 |
6% |
1.77 |
31.3 |
6.26 |
37.56 |
18% |
5.32 |
36.62 |
7.32 |
43.94 |
|
КЦРР-613/18.05.2012 |
11.06.2012 |
11.06.2012 |
Активен |
1217 |
| Toremifene |
EU/1/96/004/001 |
Fareston, Tablet, 60, mg, Pack: 30 |
Orion Corporation, Финландия |
Orion Corporation Orion Pharma - Финландия |
34.32 |
6.86 |
41.18 |
6% |
2.06 |
36.38 |
7.28 |
43.66 |
18% |
6.18 |
42.56 |
8.51 |
51.07 |
|
КЦ-1396/19.02.2010 |
19.03.2010 |
19.03.2010 |
Неактивен |
1217 |
| Medroxyprogesterone |
20000510 |
Farlutal, Tablet, 500, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Via del Commercio, Marino del Tronto, Ascoli Piceno, Italy |
59.61 |
11.92 |
71.53 |
4% |
2.38 |
61.99 |
12.4 |
74.39 |
16% |
9.54 |
71.53 |
14.31 |
85.84 |
промяна на обстоятелства НСР-7326/29.10.2015 |
HCP-9327/16.05.2016 |
02.07.2016 |
02.07.2016 |
Заличен |
1644 |
| Medroxyprogesterone |
20000510 |
Farlutal, Tablet, 500, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Via del Commercio, Marino del Tronto, Ascoli Piceno, Italy |
59.61 |
11.92 |
71.53 |
4% |
2.38 |
61.99 |
12.4 |
74.39 |
16% |
9.54 |
71.53 |
14.31 |
85.84 |
промяна на обстоятелства НСР-7326/29.10.2015 |
КЦ-3163/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
1644 |
| Medroxyprogesterone |
II-11874/18.11.2005 |
Farlutal, Tablet, 500, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Via del Commercio, Marino del Tronto, Ascoli Piceno, Italy |
93.16 |
18.63 |
111.79 |
4% |
3.73 |
96.89 |
19.38 |
116.27 |
16% |
14.91 |
111.8 |
22.36 |
134.16 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
1644 |
| Medroxyprogesterone |
20000511 |
Farlutal Depot, Suspension for injection, 500 mg/2.5 ml, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Италия |
4.17 |
0.83 |
5 |
7% |
0.29 |
4.46 |
0.89 |
5.35 |
20% |
0.83 |
5.29 |
1.06 |
6.35 |
промяна на обстоятелства НСР-7379/05.11.2015 ; Цената е вписана в регистъра на пределните цени с решение НСР-7380/05.11.2015 (в сила от 02.12.2015) |
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Заличен |
606 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 2 mg/ml - 25 ml, -, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Italy; Pfizer Service Company bvba, Белгия |
44.1 |
8.82 |
52.92 |
4% |
1.76 |
45.86 |
9.17 |
55.03 |
16% |
7.06 |
52.92 |
10.58 |
63.5 |
|
НСР-8331/26.02.2016 |
16.03.2016 |
16.03.2016 |
Активен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Italy; Pfizer Service Company bvba, Белгия |
58.73 |
11.75 |
70.48 |
4% |
2.35 |
61.08 |
12.22 |
73.3 |
16% |
9.4 |
70.48 |
14.1 |
84.58 |
промяна на обстоятелства НСР-4565/03.09.2014 |
НСР-1815/25.11.2013 |
12.12.2013 |
12.12.2013 |
Неактивен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 2 mg/ml - 5 ml, -, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Italy; Pfizer Service Company bvba, Белгия |
8.82 |
1.76 |
10.58 |
7% |
0.62 |
9.44 |
1.89 |
11.33 |
20% |
1.76 |
11.2 |
2.24 |
13.44 |
промяна на обстоятелства НСР-4565/03.09.2014 |
НСР-1815/25.11.2013 |
12.12.2013 |
12.12.2013 |
Активен |
2321 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
86.31 |
17.26 |
103.57 |
4% |
3.45 |
89.76 |
17.95 |
107.71 |
16% |
13.81 |
103.57 |
20.71 |
124.28 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
14.45 |
2.89 |
17.34 |
6% |
0.87 |
15.32 |
3.06 |
18.38 |
18% |
2.6 |
17.92 |
3.58 |
21.5 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2321 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
110.17 |
22.03 |
132.2 |
4% |
4.41 |
114.58 |
22.92 |
137.5 |
16% |
17.63 |
132.21 |
26.44 |
158.65 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
22.65 |
4.53 |
27.18 |
6% |
1.36 |
24.01 |
4.8 |
28.81 |
18% |
4.08 |
28.09 |
5.62 |
33.71 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2321 |
| Epirubicin |
II-9863/02.11.2004 |
Farmorubicin RD, Powder for solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
44.18 |
8.84 |
53.02 |
4% |
1.77 |
45.95 |
9.19 |
55.14 |
16% |
7.07 |
53.02 |
10.6 |
63.62 |
корекц. решение НСР-2590/24.01.2014; Цената е заличена с решение НСР-4567/03.09.2014( в сила от 18.09.2014) |
НСР-1816/25.11.2013 |
12.12.2013 |
12.12.2013 |
Заличен |
2320 |
| Epirubicin |
II-9862/02.11.2004 |
Farmorubicin RD, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
8.82 |
1.76 |
10.58 |
7% |
0.62 |
9.44 |
1.89 |
11.33 |
20% |
1.76 |
11.2 |
2.24 |
13.44 |
корекц. решение НСР-2590/24.01.2014; Цената е заличена с решение НСР-2808/17.02.2014 |
НСР-1816/25.11.2013 |
12.12.2013 |
12.12.2013 |
Заличен |
2319 |
| Epirubicin |
II-9863/02.11.2004 |
Farmorubicin RD, Powder for solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
44.2 |
8.84 |
53.04 |
4% |
1.77 |
45.97 |
9.19 |
55.16 |
16% |
7.07 |
53.04 |
10.61 |
63.65 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2320 |
| Epirubicin |
II-9862/02.11.2004 |
Farmorubicin RD, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
13.28 |
2.66 |
15.94 |
6% |
0.8 |
14.08 |
2.82 |
16.9 |
18% |
2.39 |
16.47 |
3.29 |
19.76 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2319 |
| Epirubicin |
II-9863/02.11.2004 |
Farmorubicin RD, Powder for solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
106.77 |
21.35 |
128.12 |
4% |
4.27 |
111.04 |
22.21 |
133.25 |
16% |
17.08 |
128.12 |
25.62 |
153.74 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2320 |
| Epirubicin |
II-9862/02.11.2004 |
Farmorubicin RD, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
16.31 |
3.26 |
19.57 |
6% |
0.98 |
17.29 |
3.46 |
20.75 |
18% |
2.94 |
20.23 |
4.05 |
24.28 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2319 |
| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, -, Pack: 2 pre-filled syringes + 2 safety needles |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
938.76 |
187.75 |
1126.51 |
4% |
10 |
948.76 |
189.75 |
1138.51 |
16% |
25 |
973.76 |
194.75 |
1168.51 |
корекц. Решение НСР-3464/16.05.2014 |
НСР-3307/24.04.2014 |
08.05.2014 |
08.05.2014 |
Активен |
2765 |
| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, mg, Pack: 2 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
945.33 |
189.07 |
1134.4 |
4% |
10 |
955.33 |
191.07 |
1146.4 |
16% |
25 |
980.33 |
196.07 |
1176.4 |
|
НСР-1037/23.08.2013 |
09.09.2013 |
09.09.2013 |
Неактивен |
2765 |
| Fulvestrant |
EU/1/03/269/001 |
Faslodex, Solution for injection, 250, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
469.4 |
93.88 |
563.28 |
4% |
10 |
479.4 |
95.88 |
575.28 |
16% |
25 |
504.4 |
100.88 |
605.28 |
Цената се заличава с решение НСР-3636/29.05.2014 ( в сила от 13.06.2014) |
НСР-79/07.06.2013 |
02.07.2013 |
02.07.2013 |
Заличен |
1880 |
| Fulvestrant |
EU/1/03/269/001 |
Faslodex, Solution for injection, 250, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
685.3 |
137.06 |
822.36 |
4% |
10 |
695.3 |
139.06 |
834.36 |
16% |
25 |
720.3 |
144.06 |
864.36 |
|
КЦРР-869/26.06.2012 |
24.07.2012 |
24.07.2012 |
Неактивен |
1880 |
| Fulvestrant |
EU/1/03/269/001 |
Faslodex, Solution for injection, 250, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
697.08 |
139.42 |
836.49 |
6% |
15 |
712.08 |
142.42 |
854.49 |
18% |
30 |
742.08 |
148.42 |
890.49 |
|
КЦ-389/07.01.2009 |
26.01.2009 |
26.01.2009 |
Неактивен |
1880 |